Article
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
Cancer causes & control : CCC - 1 Jan 2013
Gibson Todd M, Smedby Karin E, Skibola Christine F, Hein David W, Slager Susan L, de Sanjosé Silvia, Vajdic Claire M, Zhang Yawei, Chiu Brian C-H, Wang Sophia S, Hjalgrim Henrik, Nieters Alexandra, Bracci Paige M, Kricker Anne, Zheng Tongzhang, Kolar Carol, Cerhan James R, Darabi Hatef, Becker Nikolaus, Conde Lucia, Holford Theodore R, Weisenburger Dennis D, De Roos Anneclaire J, Butterbach Katja, Riby Jacques, Cozen Wendy, Benavente Yolanda, Palmers Casey, Holly Elizabeth A, Sampson Joshua N, Rothman Nathaniel, Armstrong Bruce K, Morton Lindsay M
Abstract excerpt
PURPOSE: Studies of smoking and risk of non-Hodgkin lymphoma (NHL) have yielded inconsistent results, possibly due to subtype heterogeneity and/or genetic variation impacting the metabolism of tobacco-derived carcinogens, including substrates of the N-acetyltransferase enzymes NAT1 and NAT2. METH...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
